Press Release
Pharmaceutical Solutions Provider Skila - Launches iAlliance - The
Next Generation of Alliance Management Solutions Designed to Maximize
Pharmaceutical Alliance Opportunities
|
Morris Plains, NJ, May 11, 2005- Skila, a Sela2
Company, announces the launch of iAlliance, the next generation of its
unique solutions targeted at managing the complexities of pharmaceutical
alliances.
Alliances play an increasingly critical role in the Pharmaceutical Industry.
An Alliance partner represents the opportunity to quickly acquire resources
- therapeutic expertise, market access, and marketing expertise
- and share costs and risks. As a result, Pharmaceutical Alliance
revenues have almost tripled over the last decade and currently represent
over 25% of total revenues.
While pharmaceutical alliances can be lucrative, their formation is fraught
with challenges that threaten their success which comes from its core
nature: bridge over cultural and language differences while building trust
- and moving quickly. This translates into challenges on:
1) Aligning Goal and Objectives and roles and responsibilities to ensure
smooth execution,
2) Designing a measurement infrastructure that ensures a clear focus on
maximizing critical performance criteria.
3) Developing a communications and collaborative infrastructure that improves
and accelerates decision making.
Skila's vast experience with alliances and partnerships led to the
development of ialliance, Skila's next generation Alliance Management
Solution, which was developed so that pharmaceutical alliance partners
can meet these key challenges head on. At the foundation of iAlliance
is a unique and proven methodology that provides the critical infrastructure
that alliances must have to strategically plan, maximize execution, and
measure performance so that they optimize their opportunity. iAlliance
is a turn key solution which can be established and configured within
days. Skila, not only manages the collective knowledge of the Alliance,
but also plays the role of facilitator between the partners. The solution
utilizes Skila's proprietary Intelligration® platform which,
integrates knowledge from multiple data sources into a "Single Touch
Point," as well as provides the communication and collaboration
backbone necessary to develop high performance teams.
For Immediate Release
"Product development and launches are very complicated endeavors
for the Pharmaceutical Industry. Adding an Alliance partner into this
process raises this complexity exponentially," commented Simon Mason,
Skila's Senior VP of Client Partnerships. "Our unique and
proven approach with ialliance enables pharmaceutical companies to optimize
the promised potential of alliances."
|
| About Skila |
Skila is a customer-driven
company and a leader in developing best-in- class knowledge-driven
management solutions for the pharmaceutical industry. Skila's solutions
help the pharmaceutical industry increase their marketing and brand
effectiveness and have been adopted by many of the leading companies
in the industry, such as: Boehringer Ingelheim, Roche, Eli Lilly &
Company, Allergan, and Johnson & Johnson.
Utilizing expert services, unique methodology and its Intelligration®
technology, Skila's solutions integrate critical information communicating
it to the right people, at the right time through a "Single Touch
Point." These solutions are vital to pharmaceutical organizations
in successfully managing common business challenges such as:
- Optimizing product launches
- Maximizing the impact of strategic alliances with marketing partners
- Effectively managing competitive intelligence for strategic advantage
- Maximizing share of mind with key opinion leaders
- Synchronizing measurement and performance of global brand teams
- Maximizing effectiveness between marketing, sales, and medical teams
|
| |
To receive more information,
click the button below
 |
|
